Dexmedetomidine Reduces Diabetic Neuropathy Pain in Rats through the Wnt 10a/β-Catenin Signaling Pathway

Figure 3

Western blot analysis showing the protein expression of Wnt 10a and -catenin in the spinal cord. (a, b) Wnt 10a and (c, d) β-catenin protein expression normalized to GAPDH expression on days 39, 42, and 45 after STZ injection. n=4. P<0.05 for comparisons shown. C, control; DNP, diabetic neuropathy pain; DEX, dexmedetomidine; YOH, yohimbine.

(a)

(b)

(c)

(d)